Liabilities / Assets
29th percentile
Tied with the lowest-debt nonprofits in its peer group.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.00x
Liabilities / Revenue
29th percentile
Tied with the lowest-debt nonprofits in its peer group.
Net Margin
6th percentile
Higher net margin than 6% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
8th percentile
Faster asset growth than 8% of similar nonprofits.
Revenue Growth
3rd percentile
Faster revenue growth than 3% of similar nonprofits.
Balance Sheet
Assets
Down$677,314
Down $115,111 (-15%) from 2020
Net Assets
Down$677,314
Down $115,111 (-15%) from 2020
Liabilities
Flat$0
Flat from 2020
Revenue And Expenses
Revenue
Down$252,969
Down $519,393 (-67%) from 2020
Expenses
Up$368,080
Up $127,457 (+53%) from 2020
Net Income
Down-$115,111
Down $646,850 (-122%) from 2020
Historical Trend
Filing Detail Status
This 2021 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2021 to Dec 31, 2021
Mission and Program Overview
Mission
Research towards possible treatment and cure for infantile neuroaxonal dystrophy
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2021 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $677,314
- Liabilities
- $0
- Net assets
- $677,314
- Revenue
- $252,969
- Expenses
- $368,080
- Net income
- -$115,111